SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Filings re: Registrant of ‘424B5’ Filing 1493152-23-4475


        

482  Filings
Filing emoji
 ·  Click on a Filing/Form Type¹
Filing/Form Type emoji
-D to view it
 ·  List the Documents
Document emoji
& Exhibits
Exhibit emoji
within them


        
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   25   ·  All     
Bottom



        
Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing¹   For·On·As Docs:Size             Issuer                      Filing Agent      
Currently in descending order - Sort in ascending orderSort in ascending orderSort in ascending orderSort in descending orderSort in ascending orderSort in ascending order


        
 5/10/24  Processa Pharmaceuticals, Inc.    10-Q        3/31/24   47:3.2M                                   M2 Compliance LLC/FA     
 4/29/24  Processa Pharmaceuticals, Inc.    DEFA14A                1:994K                                   M2 Compliance LLC/FA     
 4/29/24  Processa Pharmaceuticals, Inc.    DEF 14A     4/29/24    1:803K                                   M2 Compliance LLC/FA     
 4/12/24  Young David                       4          Dir.,Off.²  1:8K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 4/12/24  Stanker James H                   4          Officer²    1:7K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 4/12/24  Lin Patrick                       4          Officer²    1:7K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 4/12/24  Bigora Sian                       4          Officer²    1:7K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 4/12/24  Guy Wendy                         4          Officer²    1:7K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 4/11/24  Processa Pharmaceuticals, Inc.    8-K:7,9     4/11/24   12:2M                                     M2 Compliance LLC/FA     
  4/4/24  Processa Pharmaceuticals, Inc.    8-K:7,9      4/3/24   11:7.2M                                   M2 Compliance LLC/FA     
 3/29/24  Processa Pharmaceuticals, Inc.    10-K       12/31/23   72:23M                                    M2 Compliance LLC/FA     
 2/21/24  Processa Pharmaceuticals, Inc.    8-K:7,9     2/20/24   11:7.2M                                   M2 Compliance LLC/FA     
  2/8/24  Young David                       4          Dir.,Off.²  1:5K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
  2/7/24  Young David                       4          Dir.,Off.²  1:6K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
  2/6/24  Processa Pharmaceuticals, Inc.    8-K:8,9      2/6/24   11:224K                                   M2 Compliance LLC/FA     
  2/1/24  Lin Patrick                       4          Officer²    1:5K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 1/31/24  Ng George K                       4          Dir.,Off.²  1:5K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 1/31/24  Yorke Justin W                    4          Director²   1:5K   Processa Pharmaceuticals, Inc.    Foley & Lardner/FA       
 1/30/24  Processa Pharmaceuticals, Inc.    8-K:1,7,9   1/26/24   15:995K                                   M2 Compliance LLC/FA     
 1/29/24  Processa Pharmaceuticals, Inc.    424B4                  1:658K                                   M2 Compliance LLC/FA     
____________
 ¹  Filing/Form Types: 
Type emoji
  4    Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }.
  8-K    Current Report — Form 8-K { Item 1: Business & Operations;  2: Financial Info;  3: Securities & Trading;  4: Accountants & Accounting;  5: Governance & Management;  6: Asset-Backed Securities;  7: Disclosures;  8: Events;  9: Financials }.
  10-K    Annual Report — Form 10-K.
  10-Q    Quarterly Report — Form 10-Q.
  424B4    Prospectus – Info Previously Omitted & New Facts or Events.
  DEF 14A    Definitive Proxy Statement — Schedule 14A.
  DEFA14A    Definitive Additional Proxy Soliciting Material — Schedule 14A.
 ²  Insider:  The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer.
 
Page:  
Page 1 emoji
  2   3   4   5   6   7   8   9   10   11   12   13   14   15   ...   25   ·  All     
Top



        


Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Fri., May 17, 9:14:28.8am ET